Literature DB >> 15901848

Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity.

Ying-Hong Feng1, Lingyin Zhou, Rongde Qiu, Robin Zeng.   

Abstract

The most striking feature of a G protein-coupled receptor (GPCR) is its highly exclusive agonist specificity. This feature guarantees that a GPCR recognizes only its specific native agonist(s). In this study, we showed that two point mutations of N295S and L305Q enabled the AT(1) receptors to recognize multiple Ang II fragments. Similar to the well established constitutively active AT(1) mutant receptor N111G, the mutations of N295S and L305Q induced an increased production of basal inositol 1,4,5-phosphates in the absence of exogenous Ang II when expressed in HEK293 cells. Distinct from the N111G, however, is the fact that the increased basal activity disappeared in COS-7 cells because of the lack of endogenous Ang II fragments produced by the cells-a pseudo-constitutive activity. It is surprising that the Ang II analog [Sar(1),Ile(4),Ile(8)]Ang II and the native angiotensin II fragments Ang 1-7, Ang IV, and Ang 5-8, which are inactive in activating the wild-type receptor, activated N295S and L305Q. Results generated by lowering the Na(+) concentration suggest that the mutant N295S and L305Q may be trapped in neutral conformational states (R(N)). These data allow us to identify for the first time a novel pattern of GPCR mutations with a broad spectrum of agonist specificity, suggesting possible existence of functional GPCRs in nature that are activated through conformational "selection" rather than "induction" mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901848     DOI: 10.1124/mol.105.011601

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Authors:  Jérôme Cabana; Brian Holleran; Marie-Ève Beaulieu; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

3.  Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Authors:  Haitao Zhang; Hamiyet Unal; Russell Desnoyer; Gye Won Han; Nilkanth Patel; Vsevolod Katritch; Sadashiva S Karnik; Vadim Cherezov; Raymond C Stevens
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

4.  An angiotensin II type 1 receptor activation switch patch revealed through evolutionary trace analysis.

Authors:  Marie Mi Bonde; Rong Yao; Jian-Nong Ma; Srinivasan Madabushi; Stig Haunsø; Ethan S Burstein; Jennifer L Whistler; Søren P Sheikh; Olivier Lichtarge; Jakob Lerche Hansen
Journal:  Biochem Pharmacol       Date:  2010-03-21       Impact factor: 5.858

Review 5.  Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  Br J Pharmacol       Date:  2022-04-23       Impact factor: 9.473

Review 6.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 7.  Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.

Authors:  Carlos M Ferrario; Aaron J Trask; Jewell A Jessup
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

8.  In silico prediction of ARB resistance: A first step in creating personalized ARB therapy.

Authors:  Shane D Anderson; Asna Tabassum; Jae Kyung Yeon; Garima Sharma; Priscilla Santos; Tik Hang Soong; Yin Win Thu; Isaac Nies; Tomomi Kurita; Andrew Chandler; Abdelaziz Alsamarah; Rhye-Samuel Kanassatega; Yun L Luo; Wesley M Botello-Smith; Bradley T Andresen
Journal:  PLoS Comput Biol       Date:  2020-11-25       Impact factor: 4.475

9.  Evolutionary information helps understand distinctive features of the angiotensin II receptors AT1 and AT2 in amniota.

Authors:  Rym Ben Boubaker; Asma Tiss; Daniel Henrion; Hajer Guissouma; Marie Chabbert
Journal:  PLoS Comput Biol       Date:  2022-02-24       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.